BioSpace News Archive

Geneyx Genomex Ltd (Geneyx), an Israel-based developer of a genetic data analysis and interpretation platform, announced today that it has closed its seed round financing led by Capri Ventures and Accenture Ventures to help the company expand its global footprint and accelerate the development of its technology.

Imvax, Inc., a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies, today presented data showing the mechanisms by which IGV-001 produces broad immune activation at the Society for Immunotherapy of Cancer (SITC) Annual Meeting.

CytRx Corporation announced that Centurion BioPharma Corporation, a private wholly owned subsidiary that focuses on advancing the Company’s proprietary, albumin binding ultra-high potency LADR™ oncology drug candidates, has been invited to present plans for a world-class cancer treatment center in Las Vegas, Nevada.

Amylyx Pharmaceuticals, Inc. today presented clinical data from the Phase 2 Trial AMX-8000 (PEGASUS) trial of AMX0035 (sodium phenylbutyrate (PB) and taurursodiol (TURSO; also known as ursodoxicoltaurine) for the treatment of Alzheimer’s disease (AD).

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the Stifel 2021 Virtual Healthcare Conference on Monday, November 15 at 3:20 p.m. Eastern Time.

Equillium, Inc., a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders with high unmet medical need, announced that it will participate in fireside chat presentations at the Stifel 2021 Virtual Healthcare Conference and the Jefferies Virtual London Healthcare Conference.

Immune-Onc Therapeutics, Inc. today announced that the Company will present a scientific poster at the Society for Immunotherapy of Cancer 36th Annual Meeting (SITC 2021) being held November 10-14, 2021, in Washington, D.C., USA.

Gamida Cell Presents New Data on Nicotinamide-Enabled NK Cell Therapy at Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting

Transgene and BioInvent Present Preclinical Data Highlighting the Robust Anti-Tumoral Activity of BT-001 Oncolytic Virus at SITC 2021

EdiGene Enters Research Collaboration with the University of Wisconsin-Madison on in Vivo RNA Editing Therapies